Page last updated: 2024-08-24

aripiprazole and Restless Leg Syndrome

aripiprazole has been researched along with Restless Leg Syndrome in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Dokuz, G; Ergün, S; Topçuoğlu, V1
Gangadhar, BN; Rao, MG; Raveendranathan, D; Shiva, L; Varambally, S; Venkatasubramanian, G1
Glenmullen, J; Mattison, DR; Moore, TJ1
Khalid, I; Khalid, TJ; Rana, L; Roehrs, T1
Kokaçya, H; Savas, HA; Selek, S; Virit, O1
Bolaños-Vergaray, J; Echeverri, C; Gonzalez, R; Obaya, JC; Piquer, P1
McLean, AJ1
Kikukawa, S1

Reviews

1 review(s) available for aripiprazole and Restless Leg Syndrome

ArticleYear
Restless Legs Syndrome After Aripiprazole Discontinuation: A Case Report and Review of Literature.
    Psychiatria Danubina, 2022,Winter, Volume: 34, Issue:4

    Topics: Antipsychotic Agents; Aripiprazole; Humans; Piperazines; Restless Legs Syndrome

2022

Other Studies

7 other study(ies) available for aripiprazole and Restless Leg Syndrome

ArticleYear
Clozapine-induced restless legs syndrome treated with aripiprazole.
    The Journal of neuropsychiatry and clinical neurosciences, 2013,Spring, Volume: 25, Issue:2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Female; Humans; Piperazines; Quinolones; Restless Legs Syndrome; Schizophrenia, Paranoid

2013
Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
    JAMA internal medicine, 2014, Volume: 174, Issue:12

    Topics: Adult; Aged; Aripiprazole; Benzothiazoles; Compulsive Behavior; Consumer Behavior; Dopamine Agonists; Drug Labeling; Female; Gambling; Humans; Hyperprolactinemia; Impulsive Behavior; Indoles; Male; Middle Aged; Parkinson Disease; Piperazines; Pramipexole; Quinolones; Receptors, Dopamine D3; Restless Legs Syndrome; Retrospective Studies; Sexual Behavior; United States; United States Food and Drug Administration

2014
Refractory restless legs syndrome likely caused by olanzapine.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2009, Feb-15, Volume: 5, Issue:1

    Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Piperazines; Quinolones; Restless Legs Syndrome; Valproic Acid

2009
Improvement of restless legs syndrome and trichotillomania with aripiprazole.
    Journal of clinical pharmacy and therapeutics, 2009, Volume: 34, Issue:6

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Piperazines; Quinolones; Restless Legs Syndrome; Trichotillomania

2009
Restless legs syndrome due to aripiprazole.
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:5

    Topics: Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Piperazines; Quinolones; Restless Legs Syndrome

2011
The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndrome.
    Sleep, 2004, Aug-01, Volume: 27, Issue:5

    Topics: Adult; Aripiprazole; Dopamine Agonists; Humans; Male; Piperazines; Quinolones; Restless Legs Syndrome

2004
Effectiveness of aripiprazole in treatment of adults with attention deficit disorder and restless legs syndrome.
    The international journal of neuropsychopharmacology, 2008, Volume: 11, Issue:3

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Female; Humans; Piperazines; Quinolones; Restless Legs Syndrome

2008